|
|
Post by joeypotsandpans on Jun 20, 2021 13:17:00 GMT -5
There are reasons more than one member of this board interpret or question that posters motives. I agree the response was to Oldfish's medicare post regarding a possibility of increased scripts, but it's the nature of the tone of the response along with the successive posts after the initial response (3 consecutive posts within 25 minutes which could have easily been edited into the first of the three posts on 6/17). It just comes across at a time when some very positive FDA news was announced regarding UTHR's submission on Tyvaso (getting back on track here). I mentioned the term "paid troll" in a myriad of possibilities as I have no clue what their true motive is, but since you state with certainty they are not I guess you know them personally as you sound 100% certain of that as well that you're 100% certain they were a former MNKD sales rep. Granted it seems circumstantial enough that they were, however, this jury member has no factual evidence other than hear say and I assume nothing regarding same on a message board. I've stated previously directly to the individual that they seemed angry or bitter and suggested it seems like a cancer eating away at them to continue 2-3yrs. later of "trying to get their point across" and to just let it "the cancer" go. I would make that same suggestion to any long term disgruntled shareholder as well. Having said all that, doesn't it suck when your biological time clock is fixed so that you're awake on a Sunday morning at 4:30a Pacific time, especially on Father's Day 🤣😉. Happy Father's Day to all the pops out there!! awesomo stated: "Pguerrero broke news of Kendall’s and other c suite executive’s departures long before they were confirmed by MannKind or anyone else. Of course, that was met with the same vitriol on the message board of being a paid basher, disgruntled employee, troll, etc. So yeah, there is credibility there." Joey's take on it: Credibility? Hmm, lets take a look at what I see  PGuerrero's quote: "For the record, my closest fellow MNKD rep/confidant who taught me more about diabetes than spending 6 yrs with novo nordisk and praises Afrezza to this day (of course she left because as I have said nothing is sustainable selling Afrezza) still went to the ER twice in 2 yrs with dangerous lows. Still loves Afrezza and is taking it after leaving. So the “less hospitalizations” theory probably doesn’t work either. More real world feedback."
So in their own words: was with NOVO for 6 yrs. and didn't know as much about diabetes until they were with MNKD and the " fellow MNKD rep/confidant" who helped teach them more than NOVO ever did? WTF? Now you have someone that was with NOVO for six years and left that large stable company on their own accord? (truthfully we don't know the reason if voluntary or involuntary) to join a company with an unproven product that endo's don't want to or don't know how to sell? Hey how about this possibility, NOVO sent them over to MNKD to sabotage selling the greatest mealtime insulin in the world? Point being nothing is really known so you cannot vouch for someone's credibility other than your own personal opinion. Also, it is your opinion to use the word vitriol (cruel and bitter criticism) which I think is a bit extreme rather than just accepting others giving their opinions/assessment of one's credibility. I think it would be naive to believe that the short interest over the years has been held by retail investors/traders as opposed to largely by an entity whether it be a hedge fund, institution, etc., if you've been in this "game" as long as I have, as I stated previously, anything is possible, nothing surprises me ie., (GME, AMC, Hertz, Kodak, etc.) and trust no one. I'm not being cruel, I'm just going with the old adage: believe half of what you see and none of what you hear. One other aside, the insinuation that 2 trips to the ER for their confidant "disproves the less hospitalizations theory" is just another absurd statement as we don't know what the circumstances were behind those instances nor is 2 trips to an ER over 2 yrs. a sample size I would even begin to consider to make a claim like that. This will be my last post/response in this thread regarding this subject, if someone wants to carry on about it feel free to start a "pguerrero ex-rep?" thread |
|
|
|
Post by sportsrancho on Jun 20, 2021 13:20:45 GMT -5
Outside of what I’ve heard from talking to reps on the phone or whatever when the presentation was given at Rancho Medical years ago the Mannkind rep for that area was there … she sat down right next to me …she told me that type two older patients could not inhale it, it was to hard for them .that all they did was cough and they got right off the drug. She told me she had talked to the SNY reps because she was taking over their territory and that they had said the same thing. So I wasn’t sure if she knew it for a fact or if the Sanofi reps were trying to screw her view of the product, but I can tell you one thing I was scared to death to put it on this board because of how some of you people act. I also didn’t want to hurt a stock that I was heavily invested in. But those days are over, we have to be honest and hit this head on and come up with solutions.
I’m not scared anymore… because I have proof of what’s really happening.
And it’s exactly what Bill said was happening and would and is happening and yes he was mad as hell because he could see the writing on the wall and he wanted to help. And …BTW he also has much higher expectations of the Mannkind share price and what it could be in time than I do:-)
He knows what the potential could be if handled right.
( Think sayhey24:-))
|
|
|
|
Post by sayhey24 on Jun 20, 2021 14:54:03 GMT -5
Sports - please spell it out for me. Its fathers day and I have probably already had one to many. I have spoken with Bill a few times but not in a long time. Back then our thinking was pretty much aligned. The sweet spot for afrezza is the early T2's not the older T2's who have already been so badly cared for by the medical community that they can't even inhale any more.
If these early and "pre" diabetics are properly handled, some and probably most will never progress to the basal and most will probably not progress. If thats true think about what that would mean to to the death rates from heart disease.
I still think Dachis is on the right track if he wants to make some money out of this. The big money is in the weight loss business and his purchase of Sano could prove genius. If Mike would make him the 2u afrezza micro dose which they will probably need for the pediatrics it would be a great addition to Dachis' monthly service fee. I also think a 2u could get over the counter approval as it would be really hard for an adult who is not taking another basal/prandial to get a hypo from an afrezza micro dose.
|
|
|
|
Post by sportsrancho on Jun 20, 2021 14:58:08 GMT -5
“If these early and "pre" diabetics are properly handled, some and probably most will never progress to the basal and most will probably not progress. If thats true think about what that would mean to to the death rates from heart disease.”
Part of it yes:-)
And you have connect with all patients before they have a bad experience. Dosage/CGM training. Inhalation, empathy and follow through.
|
|
|
|
Post by cretin11 on Jun 20, 2021 15:28:57 GMT -5
Yes. Instead of trying to “sniff out a rat” by showing pguererro is an impostor (which is false), let’s focus on the positive and how to make things work better. Denying weaknesses never works, we must understand, address and correct them. Bill has the right idea.
Now let’s steer this thread back to UTHR and Tyvaso...
|
|
|
|
Post by pguererro on Jun 20, 2021 16:25:42 GMT -5
Interesting. I get on here once a week. I’m running out of inside leads cause my closest peops have come over to the company I now work for. My product is not a competitor to Afrezza. Thank you to those that have made real/true comments about my posts. I sold Afrezza for 3.5 yrs and did very well at MannKind. I was part of the original 50 reps on a contract with publicis. When I left 1.5 yrs ago I was one of 7 original reps of those 50 OG’s. As anyone who truly knows meal time insulin I knew Afrezza was gonna be a game changer for pwd. The market said no. The patients said no. It’s a simple story of a 4 billion dollar failure in the pharmaceutical market. There are no conspiracies. It’s not because of insurance coverage. It’s not because of COVID. It’s not because patients or endos don’t know about it. I hope regardless of what happens that small niche patient that is highly motivated and has never had better numbers can still get access to Afrezza. I’ve only been honest and real.
|
|
|
|
Post by peppy on Jun 20, 2021 16:32:50 GMT -5
Interesting. I get on here once a week. I’m running out of inside leads cause my closest peops have come over to the company I now work for. My product is not a competitor to Afrezza. Thank you to those that have made real/true comments about my posts. I sold Afrezza for 3.5 yrs and did very well at MannKind. I was part of the original 50 reps on a contract with publicis. When I left 1.5 yrs ago I was one of 7 original reps of those 50 OG’s. As anyone who truly knows meal time insulin I knew Afrezza was gonna be a game changer for pwd. The market said no. The patients said no. It’s a simple story of a 4 billion dollar failure in the pharmaceutical market. There are no conspiracies. It’s not because of insurance coverage. It’s not because of COVID. It’s not because patients or endos don’t know about it. I hope regardless of what happens that small niche patient that is highly motivated and has never had better numbers can still get access to Afrezza. I’ve only been honest and real. does this mean you have now told us, your job is done, and this is your sad sad farewell? |
|
|
|
Post by pguererro on Jun 20, 2021 16:44:52 GMT -5
Nope. I’ll continue to talk about what’s happening in the field. If all the sudden there is a pulse I’ll let u know. I will say I’m no longer an investor and probably only lost $10k on MNKD.
|
|
|
|
Post by pguererro on Jun 20, 2021 16:45:54 GMT -5
I will say if I was Type 1 I would use Afrezza.
|
|
|
|
Post by pguererro on Jun 20, 2021 16:47:30 GMT -5
I hope u weren’t being a smart ass peppy. I can be gullible.
|
|
|
|
Post by peppy on Jun 20, 2021 16:54:01 GMT -5
I will say if I was Type 1 I would use Afrezza. of course you would. If you could get it covered by health insurance. |
|
|
|
Post by peppy on Jun 20, 2021 16:56:35 GMT -5
I hope u weren’t being a smart ass peppy. I can be gullible. I do not see the point of coming here to tell us Afrezza will never be viable. Ok, you told us once. How many times do you feel we need to be told? Anyway, as I said before, if you want to help. you could tell us about the obstacles reps have to jump to see physicians these days. |
|
|
|
Post by morfu on Jun 20, 2021 17:00:23 GMT -5
I will say if I was Type 1 I would use Afrezza. And he/she also said:
"The patients said no.[..] It’s not because of insurance coverage."
I don´t understand this.. So you think personally that this is a good product, why do you think patients reacted differencly? I asked the same question in a different thread: How an how much does "the average Afrezza user" pay? What is the most common way?
Last not least I apologize to keep this thread hijacking going..
|
|
|
|
Post by peppy on Jun 20, 2021 17:04:35 GMT -5
I will say if I was Type 1 I would use Afrezza. And he/she also said:
"The patients said no.[..] It’s not because of insurance coverage."
I don´t understand this.. So you think personally that this is a good product, why do you think patients reacted differencly? I asked the same question in a different thread: How an how much does "the average Afrezza user" pay? What is the most common way?
Last not least I apologize to keep this thread hijacking going..
morfu, it is the insurance coverage. |
|
|
|
Post by morfu on Jun 20, 2021 17:07:10 GMT -5
And he/she also said:
"The patients said no.[..] It’s not because of insurance coverage."
I don´t understand this.. So you think personally that this is a good product, why do you think patients reacted differencly? I asked the same question in a different thread: How an how much does "the average Afrezza user" pay? What is the most common way?
Last not least I apologize to keep this thread hijacking going..
morfu, it is the insurance coverage. Okay, well .. a bit more details would be great, it seems medicare D does not cover Afrezza for example, is there a Co-pay if a different coverage is the most common?
|
|
